Home » Stocks » RDHL

RedHill Biopharma Ltd. (RDHL)

Stock Price: $7.01 USD -0.01 (-0.14%)
Updated Jun 24, 2021 1:39 PM EDT - Market open
Market Cap 327.97M
Revenue (ttm) 83.88M
Net Income (ttm) -81.88M
Shares Out 46.72M
EPS (ttm) -2.14
PE Ratio n/a
Forward PE 1,428.57
Dividend n/a
Dividend Yield n/a
Trading Day June 24
Last Price $7.01
Previous Close $7.02
Change ($) -0.01
Change (%) -0.14%
Day's Open 7.03
Day's Range 6.99 - 7.14
Day's Volume 98,835
52-Week Range 5.91 - 11.52

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

TEL AVIV, Israel and RALEIGH, NC, June 21, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced presentation of...

3 days ago - PRNewsWire

Coronavirus players may deliver strong returns well into the future.

Other stocks mentioned: GRTS, VIR
5 days ago - The Motley Fool

TEL AVIV, Israel and RALEIGH, N.C., June 9, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.

2 weeks ago - PRNewsWire

TEL AVIV, Israel and RALEIGH, NC, June 7, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has comp...

2 weeks ago - PRNewsWire

RedHill Biopharma Ltd (NASDAQ:RDHL) has reported its financial results and operational highlights for the first quarter ended March 31, 2021, with the company highlighting a strong end to the first quar...

3 weeks ago - Proactive Investors

Redhill Biopharma Ltd. (RDHL) saw its shares surge in the last session with trading volume being higher than average.

4 weeks ago - Zacks Investment Research

Shares of Redhill Biopharma (NASDAQ:RDHL) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were flat 0.00% year over year to ($0.05), which beat the estimate of...

4 weeks ago - Benzinga

TEL AVIV, Israel and RALEIGH, N.C., May 27, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.

4 weeks ago - PRNewsWire

RedHill Biopharma Ltd. (NASDAQ:RDHL) has announced the receipt of two Notices of Allowance from the US Patent and Trademark Office (USPTO) covering opaganib and RHB-107 (upamostat), as methods for the t...

4 weeks ago - Proactive Investors

Redhill Biopharma (NASDAQ:RDHL) releases its next round of earnings this Thursday, May 27. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.

4 weeks ago - Benzinga

TEL AVIV, Israel and RALEIGH, NC, May 26, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced receipt of two N...

4 weeks ago - PRNewsWire

Photo by Elsa Olofsson on Unsplash World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus recently said the COVID-19 pandemic's second year was on track to be its deadliest.

4 weeks ago - Benzinga

TEL AVIV, Israel and RALEIGH, N.C., May 24, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.

1 month ago - PRNewsWire

TEL AVIV, Israel and RALEIGH, N.C., May 21, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.

1 month ago - PRNewsWire

TEL AVIV, Israel and RALEIGH, N.C., May 20, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.

1 month ago - PRNewsWire

They're approaching the treatment-race finish line.

Other stocks mentioned: HGEN
2 months ago - The Motley Fool

TEL AVIV, Israel and RALEIGH, N.C., April 9, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.

2 months ago - PRNewsWire

RedHill Biopharma Ltd. (NASDAQ:RDHL) has announced a resolution to patent litigation in the US in response to a generic version of Movantik (naloxegol) which the company acquired the global rights to, e...

2 months ago - Proactive Investors

TEL AVIV, Israel and RALEIGH, N.C., March 25, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.

2 months ago - PRNewsWire

RedHill Biopharma Ltd. (NASDAQ:RDHL) announced that it has acted on a request to provide its opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffer...

3 months ago - Proactive Investors

TEL AVIV, Israel and RALEIGH, N.C., March 22, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.

3 months ago - PRNewsWire

RedHill Biopharma Ltd (NASDAQ: RDHL) has reported FY2020 net revenue of approximately $64 million and gross profit of $27.5 million thanks to the commercialization of its Movantik and Talicia gastrointe...

3 months ago - Proactive Investors

Shares of Redhill Biopharma (NASDAQ:RDHL) rose 0.9% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 333.33% year over year to ($0.07), which b...

3 months ago - Benzinga

TEL AVIV, Israel and RALEIGH, N.C., March 18, 2021 /PRNewswire/ -- Financials: Full year 2020 net revenues of approximately $64 million, with gross profit of approximately $27.5 million Solid cash balan...

3 months ago - PRNewsWire

Redhill Biopharma (NASDAQ:RDHL) announces its next round of earnings this Thursday, March 18. Here is Benzinga's everything-that-matters guide for this Thursday's Q4 earnings announcement.

3 months ago - Benzinga

TEL AVIV, Israel and RALEIGH, NC, March 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will r...

3 months ago - PRNewsWire

TEL AVIV, Israel and RALEIGH, NC, March 5, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will pr...

3 months ago - PRNewsWire

TEL AVIV, Israel and RALEIGH, N.C., March 4, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing o...

3 months ago - PRNewsWire

TEL AVIV, Israel and RALEIGH, NC, March 2, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that due to dem...

3 months ago - PRNewsWire

TEL AVIV, Israel and RALEIGH, N.C., March 1, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has e...

3 months ago - PRNewsWire

Following the FDA review of data from the U.S. Phase 2 study of opaganib and receipt of its recommendations, RedHill Biopharma Ltd (NASDAQ: RDHL) plans to expand its global Phase 2/3 study of opaganib i...

4 months ago - Benzinga

TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plans to ex...

4 months ago - PRNewsWire

RedHill (RDHL) doses first patient in phase II/III study of orally-administered RHB-107 (upamostat), an investigational new drug for patients with symptomatic COVID-19 who do not require hospital care.

4 months ago - Zacks Investment Research

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced agreements with Cosmo Pharmaceuticals NV to manufacture RedHill's largest selling product in the U.S., Movantik, and RHB-204, currently in a Phase 3 U....

4 months ago - Benzinga

TEL AVIV, Israel and RALEIGH, N.C., Feb. 18, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced agreements wi...

4 months ago - PRNewsWire

RedHill Biopharma Ltd (NASDAQ:RDHL) announced Wednesday that the first patient was dosed in its US Phase 2/3 study of orally-administered RHB-107 (upamostat), an investigational new drug for patients wi...

4 months ago - Proactive Investors

Are you a high-risk stock picker or cautious investor? No matter your answer, there's a stock for you on this list.

Other stocks mentioned: ABT, GRTS, MRNA
4 months ago - The Motley Fool

TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the inde...

4 months ago - PRNewsWire

This could be a key year for these companies' treatment candidates.

Other stocks mentioned: AVIR
4 months ago - The Motley Fool

TEL AVIV, Israel and RALEIGH, N.C., Jan. 14, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing o...

5 months ago - PRNewsWire

The drugmaker more than doubled the size of its planned public stock offering.

5 months ago - The Motley Fool

TEL AVIV, Israel and RALEIGH, N.C., Jan. 12, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that due to d...

5 months ago - PRNewsWire

TEL AVIV, Israel and RALEIGH, N.C., Jan. 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has e...

5 months ago - PRNewsWire

RedHill (RDHL) gets Fast Track status from the FDA for the treatment of nontuberculous mycobacteria (NTM) disease.

5 months ago - Zacks Investment Research

RedHill's (RDHL) opaganib achieves greater improvement in reducing oxygen requirement compared to placebo in a phase II study evaluating it in patients hospitalized with COVID-19 pneumonia.

5 months ago - Zacks Investment Research

TEL AVIV, Israel and RALEIGH, N.C., Dec. 31, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that prelimin...

5 months ago - PRNewsWire

Investors need to pay close attention to RedHill Biopharma (RDHL) stock based on the movements in the options market lately.

5 months ago - Zacks Investment Research

RedHill has a stable line of approved, marketed and pipeline products. Its cash balance is a little low.

6 months ago - Seeking Alpha

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 817 13F fi...

6 months ago - Insider Monkey

RedHill (RDHL) expands its manufacturing capacity to support the potential emergency use applications to be filed for opaganib to address severe COVID-19 pneumonia in the United States.

6 months ago - Zacks Investment Research

About RDHL

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infectio... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
2009
CEO
Dror Ben-Asher
Employees
182
Stock Exchange
NASDAQ
Ticker Symbol
RDHL
Full Company Profile

Financial Performance

In 2020, RDHL's revenue was $64.36 million, an increase of 923.03% compared to the previous year's $6.29 million. Losses were -$76.17 million, 80.1% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for RDHL stock is "Strong Buy." The 12-month stock price forecast is 20.43, which is an increase of 191.44% from the latest price.

Price Target
$20.43
(191.44% upside)
Analyst Consensus: Strong Buy